查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542776

冠狀動脈導管導引線的全球市場

Coronary Guidewires
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球冠狀動脈導管導引線市場預計將達到 8.072 億美元

2023年全球冠狀動脈導管導引線市場估計為5.972億美元，預計到2030年將達到8.072億美元，2023-2030年分析期間複合年成長率為4.4%。鎳鈦合金導管導引線是本報告分析的細分市場之一，預計複合年成長率為 2.9%，到分析期結束時將達到 5.502 億美元。分析期內，鋼基導管導引線市場的複合年成長率預計為 8.3%。

美國市場預計將達到1.608億美元，中國預計複合年成長率為4.3%。

預計 2023 年美國冠狀動脈導管導引線線市場規模將達到 1.608 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1.289億美元，2023-2030年分析期間複合年成長率為4.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.2% 和 3.6%。在歐洲，德國的複合年成長率預計為 3.7%。

全球冠狀動脈導管導引線市場 - 主要趨勢和促進因素總結

心臟病呈上升趨勢：世界日益嚴重的心臟病危機

心血管疾病（CVD）的全球負擔正以驚人的速度增加，並且是全球第一大死因。老化、都市化和生活方式的改變（包括不健康食品攝取量的增加、體力活動的減少和吸菸）等因素極大地促進了心臟病的盛行率。現代生活方式不僅使我們容易受到高血壓、肥胖和糖尿病等危險因素的影響，而且還加劇了醫療保健系統在管理日益增多的心臟相關疾病方面所面臨的挑戰。每年有數百萬人被診斷出患有心血管疾病，迫切需要採取更強力的預防措施、更廣泛的公共衛生宣傳活動和更容易獲得的治療方法來遏制這一日益嚴重的流行病。隨著各國努力滿足人民的醫療保健需求，數百萬人的心臟健康面臨風險，迫使世界各地的政府和組織優先考慮心血管治療和研究。

穿越心臟迷路：冠狀動脈導管導引線如何發揮作用？

冠狀動脈導管導引線是長而細的導線，心臟科醫師在血管成形術和支架置入術等手術過程中使用它來引導心臟複雜的脈管系統。這些導線可作為導管和其他器械的導引裝置，使它們能夠精確定位和治療動脈阻塞或狹窄，這是冠狀動脈疾病的常見症狀。冠狀動脈導管導引線的靈活性和強度至關重要，因為它們必須安全地穿過脆弱的血管而不造成損壞。這些線通常由不銹鋼或鎳鈦諾芯製成，具有親水塗層，可減少摩擦，並且旨在更輕鬆地穿過狹窄而曲折的動脈途徑。這種精確的可操作性對於介入手術的成功至關重要，並透過恢復正常的血流和降低心臟病發作的風險來直接影響患者的治療結果。

哪些創新將塑造冠狀動脈導管導引線的未來？

近年來冠狀動脈導管導引線的發展特點是顯著的技術進步，旨在提高基於導管的手術的易用性和有效性。現代導管導引線具有增強的扭矩控制等先進功能，可幫助醫生更精確地引導導絲。此外，混合導管導引線的開發結合了導絲不同部分的靈活性和剛度等不同特性，以適應特定手術的需求和複雜性。材料科學的創新也導致了具有微塗層表面的導管導引線的製造，從而提高了可追蹤性並減少了血管創傷。這些技術進步不僅使手術變得更安全、更有效率，而且為更複雜的冠狀動脈疾病病例提供了微創手術的可能性。

使用冠狀動脈導管導引線有哪些挑戰和風險？

儘管冠狀動脈導管導引線導管插入術中發揮重要作用，但其使用並非沒有風險和挑戰。主要問題之一是如果導線意外從血管途徑脫落，可能會造成動脈損傷。雖然這種事故很少見，但可能會導致嚴重的併發症，包括血管穿孔和隨後的出血。此外，為特定手術選擇合適的導管導引線很大程度上取決於患者冠狀動脈的解剖問題，並且需要手術外科醫生相當多的技能和經驗。此外，穿入導管導引線需要時間並且需要高精度，這在時間緊迫的緊急情況下帶來了挑戰。因此，持續的培訓和導管導引線技術的進步對於降低這些風險並提高導管導引線使用的安全性和有效性至關重要。

冠狀動脈導管導引線市場成長的驅動力是什麼？

冠狀動脈導管導引線市場的成長是由多種因素所推動的，例如全球心血管疾病盛行率的上升、冠狀動脈導管導引線的技術進步以及對微創手術的需求不斷增加。隨著世界人口老化，動脈粥狀硬化等冠狀動脈疾病的盛行率不斷增加，導致對介入性心臟病學手術的需求不斷增加。導管導引線技術的進步也提高了手術的成功率並減少了併發症，推動了醫療保健提供者的採用。此外，隨著醫療保健系統和患者越來越喜歡微創手術來縮短恢復時間並降低感染風險，對冠狀動脈導管導引線等設備的需求也在增加，我們正在遵循這條路徑。新興市場醫療基礎設施的擴大和醫療成本上升等經濟因素也促進了冠狀動脈導管導引線市場的擴張，冠狀動脈導管導引線仍然是現代心臟護理解決方案的關鍵組成部分。

調查企業範例（共42例）

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Comed BV
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP11337

Global Coronary Guidewires Market to Reach US$807.2 Million by 2030

The global market for Coronary Guidewires estimated at US$597.2 Million in the year 2023, is expected to reach US$807.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Nitinol-Based Guidewires, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the analysis period. Growth in the Steel-Based Guidewires segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$160.8 Million While China is Forecast to Grow at 4.3% CAGR

The Coronary Guidewires market in the U.S. is estimated at US$160.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$128.9 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Coronary Guidewires Market - Key Trends and Drivers Summarized

Heart Trouble on the Rise: The World's Growing Cardio Crisis

The global burden of cardiovascular diseases (CVDs) is escalating at an alarming rate, making it the leading cause of death worldwide. Factors such as aging populations, urbanization, and lifestyle changes—including increased consumption of unhealthy foods, reduced physical activity, and tobacco use—contribute significantly to the prevalence of heart diseases. Modern lifestyles not only predispose individuals to risk factors like hypertension, obesity, and diabetes but also exacerbate the challenges healthcare systems face in managing the rising tide of heart-related ailments. Each year, millions of people are diagnosed with CVDs, stressing the urgent need for enhanced preventive measures, broader public health campaigns, and more accessible treatment options to stem the tide of this growing epidemic. As countries grapple with the healthcare demands of their populations, the heart health of millions hangs in the balance, pressing governments and organizations worldwide to prioritize cardiovascular care and research.

Navigating the Heart's Labyrinths: How Do Coronary Guidewires Make a Difference?

Coronary guidewires are slender wires used by cardiologists to navigate through the complex vascular system of the heart during procedures such as angioplasty or stent placements. These wires act as a guide for catheters and other devices, allowing for accurate positioning and delivery of treatment to blocked or narrowed arteries, which are often symptoms of coronary artery disease. The flexibility and strength of coronary guidewires are critical, as they must safely traverse delicate blood vessels without causing damage. Typically made from a core of stainless steel or nitinol, these wires are engineered with a hydrophilic coating that reduces friction, enabling smoother navigation through tight and tortuous arterial pathways. This precise maneuverability is essential for the success of interventional procedures, directly impacting patient outcomes by restoring proper blood flow and reducing the risk of heart attacks.

What Innovations Are Shaping the Future of Coronary Guidewires?

The evolution of coronary guidewires over recent years has been marked by significant technological advancements aimed at enhancing their usability and effectiveness in catheter-based procedures. Modern guidewires offer advanced features such as enhanced torque control, which allows physicians to direct the wire more precisely. Additionally, the development of hybrid guidewires, which combine different features such as flexibility and stiffness in various sections of the wire, cater to specific procedural needs and complexities. Innovations in material science have also led to the production of guidewires with micro-coated surfaces that improve trackability and reduce vascular trauma. These technological enhancements not only refine the procedure by making it safer and more efficient but also expand the potential of minimally invasive techniques in treating more complex cases of coronary artery disease.

What Challenges and Risks Are Associated with the Use of Coronary Guidewires?

Despite their pivotal role in cardiac catheterization, the use of coronary guidewires is not without risks and challenges. One of the primary concerns is the potential for arterial damage, which can occur if the wire accidentally exits the vascular pathway. Such incidents, though rare, can lead to serious complications, including blood vessel perforation and subsequent bleeding. Additionally, the selection of an appropriate guidewire for a specific procedure requires significant skill and experience from the operating physician, as the choice depends heavily on the anatomical challenges of the patient’s coronary arteries. The process of threading the guidewire can also be time-consuming and requires a high level of precision, posing challenges in emergency situations where time is critical. Therefore, continuous training and advancements in guidewire technology are crucial to mitigate these risks and enhance the safety and efficacy of their use.

What Drives the Growth in the Coronary Guidewires Market?

The growth in the coronary guidewires market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, technological advancements in coronary guidewires, and the increasing demand for minimally invasive procedures. As the global population ages, the incidence of coronary artery diseases such as atherosclerosis rises, subsequently increasing the need for interventional cardiology procedures. The advancements in guidewire technology that offer greater procedural success rates and reduced complications are also encouraging their adoption among healthcare providers. Additionally, as healthcare systems and patients increasingly prefer minimally invasive surgeries for their shorter recovery times and lower infection risks, the demand for devices such as coronary guidewires that facilitate these procedures continues to grow. Economic factors such as expanding healthcare infrastructure in emerging markets and increased healthcare spending also contribute to the expansion of the coronary guidewires market, ensuring it remains a vital component of modern cardiac care solutions.

Select Competitors (Total 42 Featured) -

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Comed B.V.
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Coronary Guidewires - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Minimally Invasive Cardiac Procedures Drive Demand for Coronary Guidewires
    • Rising Global Prevalence of Coronary Artery Disease Spurs Market Growth
    • Increased Healthcare Spending in Emerging Markets Propels Guidewire Adoption
    • Aging Population Worldwide Sustains Growth in Coronary Intervention Procedures
    • Insurance Coverage Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nitinol-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Steel-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Coronary Guidewires Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION